Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT06074744
Recruiting Not applicable

Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty

NCT06074744 · tracked via the Priya Life Science Switzerland tracker
Phase
Not applicable
Started
2023-11-30
Last updated
2024-03-12

Condition(s) studied

Joint DiseasesJoint Pain

Investigational drug(s) / intervention(s)

SSNB + IPACKFNB + IPACK

SSNB + IPACK: already included in arm/group description

FNB + IPACK: already included in arm/group description

Study summary

The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is:

\- is there a benefit in functional muscle power output of the leg?

Participants will be randomized into either the intervention group or the control group and:

* receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1)
* receive Femoral Nerve Block (FNB) + IPACK in control group (group 2)

Researchers will compare the 2 groups to see if there are differences in :

* functional muscle power output of the leg?
* muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria: * age \> 18yrs * primary TKA * BMI 35kg/m2 or less * able to give informed consent as documented by signature * clinical history without any contraindications for the planned intervention Exclusion criteria: * age \< 18 years * revision-TKA * BMI \>35kg/m2 * absent contact information * inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases * pregnancy * inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc. * withdrawal from the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Luzerner Kantonsspital Lucerne Switzerland Recruiting

More Luzerner Kantonsspital trials in Switzerland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06074744 on ClinicalTrials.gov ↗ ← All trials in Switzerland